🇺🇸 FDA
Patent

US 7501132

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7501132 (Multiple antigenic peptides immunogenic against Streptococcus pneumonia) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00, A61K39/00, A61P, A61P37/04